Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial. - Horn DB; Aronne LJ; Wharton S; Bays HE; le Roux CW; Srinath R; Gomez-Valderas E; Arad AD; Das S; Dunn JP; Ribeiro A; Glass LC; et al. (Lancet (London, England), 2026)